Change in Diuretic Dose after Initiation of a SGLT2 Inhibitor in Patients with Heart Failure with Reduced Ejection Fraction

Authors

R. Wildemann, PharmD, Thomas Jefferson UniversityFollow
D. G. Karalis, MD, FACC, FNLA, Cardiology Consultants of Philadelphia
N. Mirachi, PA-C, Cardiology Consultants of Philadelphia
B. Thoma, PharmD, BCPS, BCCP, Thomas Jefferson UniversityFollow

Files

Description

Study Purpose: To identify change in loop diuretic dose when initiating a SGLT2i in patients with HFrEF who are on a stable dose of loop diuretic in the outpatient setting

Publication Date

4-2022

Keywords

SGLT2i, heart failure, diuretics

Disciplines

Pharmacy and Pharmaceutical Sciences

Comments

Presented on 4/28/2022 at the ISHLT 2022 Conference

Recommended Citation

Wildemann, PharmD, R.; Karalis, MD, FACC, FNLA, D. G.; Mirachi, PA-C, N.; and Thoma, PharmD, BCPS, BCCP, B., "Change in Diuretic Dose after Initiation of a SGLT2 Inhibitor in Patients with Heart Failure with Reduced Ejection Fraction" (2022). College of Pharmacy Posters. 25.
https://jdc.jefferson.edu/pharmacyposters/25